SCHEMBL120897

SCHEMBL120897

CCC(CC(C)c1ccc(OC(C)(C)C)cc1)c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.44
ESR2 Q92731 5/20 0.44
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
PGR P06401 1/20 0.39
CHRM2 P08172 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
AR P10275 1/20 0.39
CYP2D6 P10635 1/20 0.39
CHRM1 P11229 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
DRD1 P21728 1/20 0.39
TBXA2R P21731 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
CYP2C19 P33261 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19820889 0.87 TRPA1 (0.43) CHRM2CHRM1ADRA1ASLC6A3ACACB
SCHEMBL19820874 0.86 GRIA4 (0.44) MAPTSLC6A2SLC6A3ACACBALDH1A1
SCHEMBL12384051 0.84 ESR1 (0.58) ESR1ESR2MAPTLMNACYP1A2
SCHEMBL18293575 0.84 CYP17A1 (0.40) MAPTLMNACYP1A2CYP3A4CYP2D6
SCHEMBL13098430 0.84 ESR1 (0.40) ESR1ESR2MAPTLMNACYP1A2
SCHEMBL119569 0.82 ELANE (0.46) ESR1ESR2MAPTLMNACYP1A2
SCHEMBL14427949 0.82 ELANE (0.46) ESR1ESR2MAPTLMNACYP1A2
SCHEMBL16200769 0.81 ESR1 (0.55) ESR1ESR2MAPTLMNACYP1A2
SCHEMBL16200764 0.81 ESR1 (0.55) ESR1ESR2MAPTLMNACYP1A2
SCHEMBL13294722 0.81 ESR1 (0.55) ESR1ESR2MAPTLMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9217919-B2 Photosensitive composition, pattern-forming method using the composition, and resin used in the composition FUJIFILM CORPORATION (JP) 2015-12-22 US disclosed
US-8304177-B2 Process for producing ink jet head CANON KABUSHIKI KAISHA (JP) 2012-11-06 US disclosed
US-8142977-B2 mixture of resin which decomposes under acid under exposure to actinic radiation, acid generator FUJIFILM CORPORATION (JP) 2012-03-27 US disclosed
US-20120058433-A1 PROCESS FOR PRODUCING INK JET HEAD CANON KABUSHIKI KAISHA (JP) 2012-03-08 US disclosed
US-20110159433-A1 PHOTOSENSITIVE COMPOSITION, PATTERN-FORMING METHOD USING THE COMPOSITION, AND RESIN USED IN THE COMPOSITION FUJIFILM CORPORATION (JP) 2011-06-30 US disclosed
US-20080241749-A1 POSITIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110159433-A1 PHOTOSENSITIVE COMPOSITION, PATTERN-FORMING METHOD USING THE COMPOSITION, AND RESIN USED IN THE COMPOSITION SUN2, LCP1, PHYKPL ESR1 1396/4885ESR2 1722/4885MAPT 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.